Läkemedelsindustriföreningen

Tweet this page
<
2017
2018
2019
2020
2021
2022
2023
2024
2025
>
Registration as it was on 11 Jan 2025
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

1.5 Fte (5)

Lobbyists with EP accreditation

0

High-level Commission meetings

3

Lobbying Costs over the years

  • Info

    Läkemedelsindustriföreningen   (Lif)

    EU Transparency Register

    544344129150-31 First registered on 05 Dec 2017

    Goals / Remit

    Lif är branschorganisationen för de forskande läkemedelsföretagen i Sverige. Vi arbetar för en högkvalitativ vård och tillgång till nya behandlingar genom att stärka den svenska Life Science-sektorn i samverkan med vårdens aktörer, politiker, tjänstemän och patientföreträdare.

    Main EU files targeted

    EU Pharma legislation
    EU Patent Package
    EHDS
    AI ACT
    EU Pharmaceutical Incentives Analysis.
    EU HTA Regulation
    IHI
    AMR
    Pharmacueticals in the environment (PiE)

    Address

    Head Office
    Läkemedelsindustriföreningen
    Stockholm 11892
    SWEDEN
    EU Office
    Läkemedelsindustriföreningen
    Stockholm 11892
    SWEDEN

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    50%1
    25%4

    Lobbyists (Full time equivalent)

    1.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade and business associations

  • Networking

    Affiliation

    Svenskt Näringsliv
    EFPIA
    AESGP
    IMM (institutet mot mutor)
    IFPMA
    EUCOPE

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    ingen

    Other activities

    None declared

  • Meetings

    Meetings

    3 meetings found. Download meetings

    The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 11 Feb 2025 Location Brussels, Belgium
      Subject Exchange of views on EU policies in the areas of life science and biotechnology
      DG Health and Food Safety
      Attending
      • Rainer Becker (Director)
    • Date 11 Feb 2025 Location Brussels, N105
      Subject The current state of the EU pharmaceutical sector, ways to strengthen EU competitiveness, the forthcoming Life Sciences Strategy and Biotech Act
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Giulia Del Brenna (Head of Unit)
    • Date 15 Feb 2018 Location Brussels
      Subject pharmaceutical IP incentives
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Fabrice Comptour (Cabinet member)
      • Kaius Kristian Hedberg (Cabinet member)
      Other Lobbyists
Download this datacard